Thus, given the presence of an ER binding site in the promoter of this miRNA, according to the ChIP-seq data, it can be expected that a high level of miR-190b in ER+ and/or PR+ breast tumors is due to the increased expression and activity of ER. The gene discussed is PGR; the disease is breast neoplasm.